Научная статья на тему 'A comparative Studyon the pharmacokinetics ofalisma orientalis and its compatibility'

A comparative Studyon the pharmacokinetics ofalisma orientalis and its compatibility Текст научной статьи по специальности «Фундаментальная медицина»

CC BY
71
13
i Надоели баннеры? Вы всегда можете отключить рекламу.
Ключевые слова
RHIZOMA ALISMATIS / PHARMACOKINETICS / ALCOHOL A-24-ACETATE / HPLC-MS/MS

Аннотация научной статьи по фундаментальной медицине, автор научной работы — Li Jiaxin, Yu Sun, Liu Kaixin, Zhang Yuchi, Liu Xiaonan

Rhizoma Alismatis is the composition of the treatment of type Ⅱ diabetes experience of one of the three flavors of Citrus grandis,modern pharmacological indicate that it have fuction include diuretic, lowering blood pressure, lowering blood sugar, anti-atherosclerosis, immune regulation and so on.The results of the study on the pharmacokinetic process of the active ingredient in rat rats after administration of Citrobenzene and Alisma orientalis respectively showed that Alisma Ophiopogon japonicus could increase its active ingredient, A-24-acetate absorbs in the body and reduces its plasma clearance

i Надоели баннеры? Вы всегда можете отключить рекламу.
iНе можете найти то, что вам нужно? Попробуйте сервис подбора литературы.
i Надоели баннеры? Вы всегда можете отключить рекламу.

Текст научной работы на тему «A comparative Studyon the pharmacokinetics ofalisma orientalis and its compatibility»

A COMPARATIVE STUDYON THE PHARMACOKINETICS OFALISMA ORIENTALIS AND ITS COMPATIBILITY

Jiaxin Li1, SunYu1, Kaixin Liu1, Yuchi Zhang1, Xiaonan Liu1, Pengyang Yu1, Qijing Huang1, Pengling Ge *

IDepartment of Pharmacology, School of Basic Medical Sciences, Heilongjiang University of Chinese Medicine, Harbin 150040, China; Corresponding authors: Pengling Ge, Department of Pharmacology, School of Basic Medical Sciences, Heilongjiang University of Chinese Medicine, 24 Heping Road, Harbin 150040, China; E-mail: [email protected]

Abstract Rhizoma Alismatis is the composition of the treatment of type E diabetes experience of one of the three flavors of Citrus grandis,modern pharmacological indicate that it have fuction include diuretic, lowering blood pressure, lowering blood sugar, anti-atherosclerosis, immune regulation and so on.The results of the study on the pharmacokinetic process of the active ingredient in rat rats after administration of Citrobenzene and Alisma orientalis respectively showed that Alisma Ophiopogonjaponicuscouldincreaseitsactiveingredient,A-24-acetateabsorbsinthebodyandreducesitsplasmaclearance.

Key words Rhizoma Alismatis ; Alcohol A-24-Acetate ; Pharmacokinetics ; HPLC-MS/MS

Objective To study the pharmacokinetic differences of Alisma orientalis and Alisma orientalis in rats.

Materials and methods Twenty - four SD rats were randomly divided into two groups, name-

ly, Huaqizeren group and Alisma group.According to 1mL / 100g body weight were given to the flower flag Ze, Alisma water decoction,take blood by the orbital venous plexus about 0.5mL before administration and after administration 0,0.25,0.5,0.75,1,2,3,4,6,8,12,24,48 h,determination of Alcohol A-24-Acetate by Liquid Chromatography / Quadruple-Flying Time Series Liquid Chromatography after processing0

Results and discussion Compared with Alisma group, the curve of Alcohol A-24-acetate was still bimodal0 However, it was found that the first peak time (Tmax) of the A-24-acetate was prolonged and the peak concentration (Cmax) did not change significantly0 The results showed that the effect of the combination of Citizen Zygren on the concentration of A-24-acetate in the evening was not obvious0 However, AUC0-t increased significantly, the elimination rate CL decreased, and was statistically significant (P <0.05), indicating that the compatibility of Alisma alcohol A-24-acetate the first peak time to extend0 At the same time, plasma clearance rate decreased, extending its role in the body time.It can be concluded that the degree of absorption of Alcohol A-24-acetate in the Citro-blazuron group was higher than that in the Alisma orientalis group and the plasma clearance rate was decreased.

References:

j^G P, Lou F C.Isolation and indentificartion of diterpnoids from Alisma orientalis[J]. Acta pharmaceutica sinica. 2002, 37:

[21 Zang Ping. Alisma research status and prospects [J]. Chinese Traditional Medicine Modern Distance Education, 2009,7 (6): 180-182.

[3] Wang Lixin, Wu Qidan, Zhang Qiao, etc. Alisma diarrhea in the study of active substances [J]. West China Pharmaceutical Journal, 7008, 23 (6): 670-672.

[4] Gu Shijian, Wu Juan, Liu Dongyue, Liu Ping, FangNianbo, Yu Shanggong. Alisma Decoction on mice blood pressure experimental study [J]. Shi Zhenguo medicine, 2010,02: 272-273.

[5] Yu Xiangyun, Zhong Jianhua, Zhang Xu. Alisma lipid-lowering pharmacological effects and material basis [J]. Chinese Journal of Traditional Chinese Medicine, 2010, 11: 250.

[6] YIN Chun-ping, WU Ji-zhou.Advances in immunoregulation of Alisma orientalis and its active components [J]. Chinese Traditional Medicine, 2001, 32 (12): 1132-1133.

a ZHANG Rui-fang, WAN Jian-xin, XU Yan-fang, YOU Dan-yu, CUI Jiong, PAN Yang-bin.Effects of Alisma alcohol B on C3a-mediat-human renal tubular epithelial cell mesenchymal transdifferentiation [J]. Chinese Journal of Integrated Traditional Chinese and Western Medicine , 2012, 10: 1407-1412.

[8] Wang Zhenhai, An Xizhong, Ren Zengchao. Protective effect of Alisma orientalis on acute liver injury in rats [J]. Chinese Journal of Animal Quarantine, 2010,09: 56-57.

[9] Gao Hong, Hu Yinghe. New use of Alisma orientalis found by the method of screening with agonist M1 receptor agonist [P]. Chinese Patent: CN 1615981.

THEPROSPECTS OF ANTI-PLATELETFUNCTION OF ASPIRIN

Jin Wang , Xue -Ying Yan*,Yan-Hua Zhu,Hui Su

Heilongjiang University of Chinese Medicine, P.R.China 150040; Corresponding author: Xue-YingYan, Address: Heping Road 24, Harbin 150040, School of Pharmacy, Heilongjiang University of Chinese Medicine, P.R.ChinaE-

mail:[email protected]

Abstract Aspirin is integral to the secondary prevention of cardiovascular disease and acts to impair the development of platelet-mediatedatherothromboembolic eventsbyirreversibleinhibitionofplateletcyclooxygenase-1(COX-1).Although aspirin is still effective, alarge number ofpatients will stilloccur atheroscleroticthromboembolic events, Besides that about 10% of patientsdo notrespond toaspirin,this phenomenon is called"aspirin resistance ".In this paper,we discussthemech-anism of aspirin resistance with these factors involved in aspirin resistance, and then analyze the potential mechanism of antiplatelet function, and provide a potential theoretical basis for promoting the formation of new antithrombotic drugs.

32

Амурский медицинский журнал №4 (20) 2017

i Надоели баннеры? Вы всегда можете отключить рекламу.